Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03075176 · ClinicalTrials.gov registry record · NA
Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy
A NA study, sponsored by University of Utah.
- Terminated
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT03075176: Clinical Trial NA study, sponsored by University of Utah.
NCT03075176 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03075176, a NA study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This study evaluates the difference in results between eyes that have been treated wavefront optimized laser vision correction (either LASIK or Photorefractive Keratectomy) compared to eyes treated with topography-guided laser vision correction (either LASIK or Photorefractive Keratectomy). Each participant will receive wavefront optimized correction in one eye and topography-guided correction in the other.
Primary Outcome
Uncorrected visual acuity will be tested pre-operatively through month 12
Interventions
- DEVICE Wavefront optimized LASIK
- DEVICE Wavefront optimized Photorefractive Keratectomy
- DEVICE Topography-guided LASIK
- DEVICE Topography-guided Photorefractive Keratectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2019-08-12 |
| Phase | NA |
Why NCT03075176 stopped before completion
NCT03075176 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Wavefront optimized LASIK is the first listed.
NCT03075176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03075176 about?
NCT03075176 is a clinical study titled "Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy". This study evaluates the difference in results between eyes that have been treated wavefront optimized laser vision correction (either LASIK or Photorefractive Keratectomy) compared to eyes treated with topography-guided laser vision correction (either LASIK or Photorefractive Keratectomy). Each par...
What is the current status of trial NCT03075176?
This trial is currently terminated. It is a NA study. The enrollment target is 39 participants. The study started on 2017-02-13. Estimated completion is 2019-08-12.
What interventions are being tested in trial NCT03075176?
The interventions under investigation include: Wavefront optimized LASIK (DEVICE), Wavefront optimized Photorefractive Keratectomy (DEVICE), Topography-guided LASIK (DEVICE), Topography-guided Photorefractive Keratectomy (DEVICE).
Who is sponsoring clinical trial NCT03075176?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03075176's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI